TWiV reviews rhinovirus complications in infants, a new influenza antiviral drug, Oropouche fever in Brazil, measles in Maryland and Ohio, effect of eliminating non-medical vaccine exemptions in NY, foot-and-mouth disease in Europe, severe primary and secondary dengue infections, and therapeutic mitigation of measles-like immune amnesia and exacerbated disease after prior respiratory virus infections.
Hosts: Vincent Racaniello, Dickson Despommier, Rich Condit, and Angela Mingarelli
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode- MicrobeTV Discord Server
- MicrobeTV store at Cafepress
- Become a member of ASV (asv.org)
- Research assistant position in Rosenfeld Lab CBER/FDA (pdf)
- The New City by Dickson Despommier
- Viruses of Microbes 2024
- Infant rhinovirus bronchiolitis contribution to hospital bed and vent use (JAMA Net Open)
- Onradivir new influenza antiviral (Lancet)
- Oropouche fever in Brazil (PAHO)
- Maryland and Ohio measles
- Repealing school vaccination exemptions (JAMA New Open)
- Increases risk of FMDV entry into Europe (pig333)
- Severe primary and secondary dengue (Nat Med)
- Mitigation of measles immune amnesia and exacerbated disease (Nat Comm)
- Letters read on TWiV 1087
- Timestamps by Jolene. Thanks!
Dickson – For Your Processing Pleasure: The Sharpest Pictures of Jupiter’s Volcanic Moon Io in a Generation Angela – Whale Scientists Rich – Benefit-risk assessment of vaccines; The Brighton collaboration standardized module for vaccine benefit-risk assessment; Vaccine adverse events: causal or coincidental?; Austin area Singing Valentines Vincent – International Day of Women and Girls in Science, 11 February
Intro music is by Ronald Jenkees
Send your virology questions and comments to twiv@microbe.tv